This is a $1,416.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Testosterone CYP 200 mg/mL. The contract is not set aside and has an ultimate completion date of June 11, 2025. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies in support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of testosterone cypionate 200 mg/mL, a specialty medication. The delivery order has a ceiling value of $1,399.09 and a performance period ending on July 25, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,599.84 firm fixed-price contract is for the delivery of testosterone cypionate 200 mg/mL medication, with a completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,018.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical sourcing and distribution company. The contract is for the delivery of testosterone cypionate 200 mg/mL medication to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a testosterone gel product. The contract has a firm fixed price of $1,273.28 and a period of performance through May 13, 2025. The contract is not set aside and was awarded on May 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,279.27, is for the delivery of testosterone cypionate 200 mg/mL medication. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 1, 2025. The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of testosterone cypionate 200 mg/mL. The contract has a ceiling value of $1,343.66 and is a firm fixed-price arrangement. The period of performance extends through September 5, 2024. This order appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Testosterone 1% (25mg/2.5g) medication, with a ceiling value of $1,174.05 and a performance period through May 9, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,193.70, is for the delivery of a testosterone 1% medication product (50 mg/5 g) with a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Testosterone Cypionate 200 mg/mL. The contract, valued at $2,240.67, was awarded by the Defense Logistics Agency (DLA) and has a completion date of December 3, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. No set-aside designation was used for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...